2013 Symposium

The CMLD-BU hosted Boston University’s 14th Annual Symposium

Chemical Synthesis: Advances and Applications

on Friday June 28th, 2013

2013 Poster-page-001

The CMLD-BU thanks the speakers, sponsors, vendors, and all those who participated for making the Symposium a great success.

Julian Adams, Ph.D., President Research and Development at Infinity Pharmaceuticals
The Discovery and development of Hsp90 Inhibitor: Retaspimycin HCI (IPI-504) for Lung Cancer

Professor Huw Davies, Emory University
Carbenoid Approach to C-H Functionalization

Professor James Bradner, Dana Farber Cancer Institute
Chemical Modulation of Chromatin Function

Professor M. Christina White, University of Illinois at Urbana-Champaign
C—H Oxidation & Organic Synthesis

We thank the following companies for their generous sponsorship of the 2013 Symposium:

abbvie astrazeneca
celgene bristolmyers
H3 perkinelmer
pfizer sigma-aldrich-logo
strem_chemicals vertex

Vendors and Other Supporters

acd_labs bu-cic
cem chemglass
interchim grace
silicycle fisher